why choose us

First received: February 22, 2023

Clinical Trial: Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gastric Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial

Brief Summary: This phase II clinical trial tests how well robotic cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in treating patients with gastric cancer that has spread to the tissue that lines the wall of the abdominal cavity (peritoneum).Gastric cancer is the third leading cause of cancer related deaths worldwide and peritoneal metastasis are found in 30% of patients at time of diagnosis.Patients with peritoneal metastasis have poor survival rates.Traditional surgery is done with a large incision and has…

Read more